Geron | GERN - Interest Expense On Debt

Stock Price
1.30
Daily Change
-0.11 -7.50%
Monthly
-23.37%
Yearly
1.97%
Q2 Forecast
1.36

Geron reported $7.15M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Amgen USD 657M 4M Mar/2026
Bio Techne USD 2.17M 9K Dec/2025
Cassava Sciences USD 108.37M 396.06M Mar/2026
Cytokinetics USD 33.34M 3M Mar/2026
Esperion Therapeutics USD 22.64M 585K Dec/2025
Exelixis USD 23.4M 3.9M Sep/2023
Genmab DKK 10M 27M Dec/2025
Geron USD 7.15M 150K Mar/2026
Gilead Sciences USD 240M 15M Mar/2026
Incyte USD 569K 13K Mar/2026
MacroGenics USD 3.34M 2.54M Sep/2025
Novartis USD 343M 39M Mar/2026
Novavax USD 5.82M 342K Dec/2025